Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value

Jing Li1, Hui Tan2,3, Tianhong Xu1

  • 1Department of Hematology, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.

Annals of Hematology
|August 20, 2021
PubMed
Abstract

Insights

18F-FDG PET-CT imaging patterns in bone marrow (BM) can predict outcomes for multiple myeloma (MM) patients. Diffuse or mixed BM uptake indicates higher tumor burden and poorer survival, establishing BM imaging as a reliable prognostic tool for MM.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled plasma cell proliferation.
  • Accurate prognostic markers are crucial for tailoring MM treatment strategies.
  • 18F-FDG PET-CT offers functional imaging insights into metabolic activity within the bone marrow.

Purpose of the Study:

  • To assess the prognostic significance of bone marrow (BM) imaging patterns identified by 18F-FDG PET-CT in multiple myeloma (MM).
  • To establish a reliable image interpretation cut-off for defining distinct BM tracer uptake patterns.
  • To validate these findings in an independent prospective cohort.

Main Methods:

  • Retrospective analysis of 18F-FDG PET-CT scans and clinical data from 100 healthy controls and 172 newly diagnosed MM patients.
  • Defined a positivity cut-off for pathological BM uptake as uptake > liver SUVmean.
  • Classified BM FDG uptake patterns into normal, focal, diffuse, and mixed, evaluating their clinical correlation and prognostic value.

Main Results:

  • In the MM cohort, 23.3% showed normal BM uptake, 34.9% focal, 3.5% diffuse, and 38.4% mixed patterns.
  • Diffuse/mixed patterns correlated with high tumor burden and inferior progression-free survival (PFS) and overall survival (OS).
  • BM uptake pattern was an independent prognostic factor, with diffuse/mixed patterns linked to significantly poorer OS and PFS (p < 0.05).

Conclusions:

  • An 18F-FDG uptake higher than the liver serves as a valid cut-off to distinguish physiological from pathological BM uptake.
  • Four distinct BM FDG uptake patterns (normal, focal, diffuse, mixed) can be defined.
  • BM FDG uptake patterns are reliable prognostic predictors in patients with multiple myeloma.